I’m writing about the challenges and risks involved in transferring patients from the ICU to medical wards or step-down units, especially in hospitals with closed ICUs where care teams differ. I’m seeking insights from U.S.-based physicians (hospitalists, intensivists, or transition-of-care specialists) with clinical experience.
Please answer any of the following questions and include your full name, title, specialty, institution, and location for verification and attribution. Responses will be quoted by name with permission.
What are the most common pitfalls or errors you have observed during ICU-to-ward transfers?
How does the structure of a closed ICU impact communication and patient safety during these transitions?
What strategies or protocols have you found effective in improving the safety and seamlessness of ICU step-downs?
Are there specific tools, checklists, or team practices that can reduce risks during ICU discharges?
posted6/24/2025
deadline6/26/2025
processing
published9/23/2025
Recently published by Medscape
Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts
Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care
I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research.
Questions:
What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)?
Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy?
What role do biologic or precision-medicine therapies play in COPD and asthma management today?
What barriers exist in implementing these newer approaches (cost, access, adherence)?
How can primary care providers best incorporate or refer for these innovations?
Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years?
Consent Note:
By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).